These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2541102)
1. No-carrier-added synthesis of 3-[18F]fluoro-1-(2-nitro-1-imidazolyl)-2-propanol. A potential PET agent for detecting hypoxic but viable tissues. Hwang DR; Dence CS; Bonasera TA; Welch MJ Int J Rad Appl Instrum A; 1989; 40(2):117-26. PubMed ID: 2541102 [TBL] [Abstract][Full Text] [Related]
2. A robotic synthesis of [18F]fluoromisonidazole ([18F]FMISO). Chang CW; Chou TK; Liu RS; Wang SJ; Lin WJ; Chen CH; Wang HE Appl Radiat Isot; 2007 Jun; 65(6):682-6. PubMed ID: 17379530 [TBL] [Abstract][Full Text] [Related]
3. Fully automated one-pot synthesis of [18F]fluoromisonidazole. Tang G; Wang M; Tang X; Gan M; Luo L Nucl Med Biol; 2005 Jul; 32(5):553-8. PubMed ID: 15982586 [TBL] [Abstract][Full Text] [Related]
4. A radiosynthesis of fluorine-18 fluoromisonidazole. Grierson JR; Link JM; Mathis CA; Rasey JS; Krohn KA J Nucl Med; 1989 Mar; 30(3):343-50. PubMed ID: 2738663 [TBL] [Abstract][Full Text] [Related]
5. An efficient radiosynthesis of [18F]fluoromisonidazole. Lim JL; Berridge MS Appl Radiat Isot; 1993 Aug; 44(8):1085-91. PubMed ID: 8358398 [TBL] [Abstract][Full Text] [Related]
6. Introducing fluorine-18 fluoromisonidazole positron emission tomography for the localisation and quantification of pig liver hypoxia. Piert M; Machulla H; Becker G; Stahlschmidt A; Patt M; Aldinger P; Dissmann PD; Fischer H; Bares R; Becker HD; Lauchart W Eur J Nucl Med; 1999 Feb; 26(2):95-109. PubMed ID: 9933343 [TBL] [Abstract][Full Text] [Related]
7. Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole. Read SJ; Hirano T; Abbott DF; Sachinidis JI; Tochon-Danguy HJ; Chan JG; Egan GF; Scott AM; Bladin CF; McKay WJ; Donnan GA Neurology; 1998 Dec; 51(6):1617-21. PubMed ID: 9855512 [TBL] [Abstract][Full Text] [Related]
8. Automated PET Radiotracer Manufacture on the BG75 System and Imaging Validation Studies of [18F]fluoromisonidazole ([18F]FMISO). Yuan H; Frank JE; Merrill JR; Hillesheim DA; Khachaturian MH; Anzellotti AI Curr Radiopharm; 2016; 9(3):235-243. PubMed ID: 27562785 [TBL] [Abstract][Full Text] [Related]
9. Noninvasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography. Martin GV; Caldwell JH; Graham MM; Grierson JR; Kroll K; Cowan MJ; Lewellen TK; Rasey JS; Casciari JJ; Krohn KA J Nucl Med; 1992 Dec; 33(12):2202-8. PubMed ID: 1460516 [TBL] [Abstract][Full Text] [Related]
10. Rapid synthesis of 3-[18F]fluoro-1-(2'-nitro-1'-imidazolyl)-2-propanol ([18F]fluoromisonidazole). Cherif A; Yang DJ; Tansey W; Kim EE; Wallace S Pharm Res; 1994 Mar; 11(3):466-9. PubMed ID: 8008718 [No Abstract] [Full Text] [Related]
11. Reduction of fluoromisonidazole, a new imaging agent for hypoxia. Prekeges JL; Rasey JS; Grunbaum Z; Krohn KH Biochem Pharmacol; 1991 Nov; 42(12):2387-95. PubMed ID: 1764122 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue. Jerabek PA; Patrick TB; Kilbourn MR; Dischino DD; Welch MJ Int J Rad Appl Instrum A; 1986; 37(7):599-605. PubMed ID: 3021662 [TBL] [Abstract][Full Text] [Related]
13. Fully automated synthesis of [18F]fluoromisonidazole using a conventional [18F]FDG module. Oh SJ; Chi DY; Mosdzianowski C; Kim JY; Gil HS; Kang SH; Ryu JS; Moon DH Nucl Med Biol; 2005 Nov; 32(8):899-905. PubMed ID: 16253816 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of [(18)F]FMISO in a flow-through microfluidic reactor: Development and clinical application. Zheng MQ; Collier L; Bois F; Kelada OJ; Hammond K; Ropchan J; Akula MR; Carlson DJ; Kabalka GW; Huang Y Nucl Med Biol; 2015 Jun; 42(6):578-84. PubMed ID: 25779036 [TBL] [Abstract][Full Text] [Related]
16. Noninvasive assessment of hypoxia with 3-[18F]-fluoro-1-(2-nitro-1-imidazolyl)-2-propanol ([18F]-FMISO): a PET study in two experimental models of human glioma. Corroyer-Dulmont A; Pérès EA; Petit E; Durand L; Marteau L; Toutain J; Divoux D; Roussel S; MacKenzie ET; Barré L; Bernaudin M; Valable S Biol Chem; 2013 Apr; 394(4):529-39. PubMed ID: 23399636 [TBL] [Abstract][Full Text] [Related]
17. 9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): a potential imaging agent of viral infection and gene therapy using PET. Alauddin MM; Conti PS; Mazza SM; Hamzeh FM; Lever JR Nucl Med Biol; 1996 Aug; 23(6):787-92. PubMed ID: 8940722 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of 4-bromo-1-(3-[18F]fluoropropyl)-2-nitroimidazole with a low energy LUMO orbital designed as brain hypoxia-targeting imaging agent. Yamamoto F; Aoki M; Furusawa Y; Ando K; Kuwabara Y; Masuda K; Sasaki S; Maeda M Biol Pharm Bull; 2002 May; 25(5):616-21. PubMed ID: 12033502 [TBL] [Abstract][Full Text] [Related]
19. The possibility of a fully automated procedure for radiosynthesis of fluorine-18-labeled fluoromisonidazole using a simplified single, neutral alumina column purification procedure. Nandy S; Rajan MG; Korde A; Krishnamurthy NV Appl Radiat Isot; 2010 Oct; 68(10):1937-43. PubMed ID: 20493720 [TBL] [Abstract][Full Text] [Related]
20. Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucose. Bentzen L; Keiding S; Horsman MR; Falborg L; Hansen SB; Overgaard J Acta Oncol; 2000; 39(5):629-37. PubMed ID: 11093372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]